معرفی
Dr. Frederick M MacDonnell is a Professor in the Department of Chemistry and Biochemistry at The University of Texas at Arlington (UTA), College of Science. With a distinguished career spanning several decades, he has established himself as a leading researcher in inorganic chemistry, photochemistry, and catalysis. His work bridges fundamental chemical research with practical applications in energy production and cancer therapeutics.
Dr. MacDonnell's research program focuses on two major areas: the development of ruthenium polypyridyl complexes for cancer treatment and heterogeneous catalysis for fuel production. His laboratory investigates the therapeutic potential and mechanisms of action of ruthenium-based compounds, particularly their ability to target microtubules and cleave DNA under hypoxic conditions. In the energy sector, his research explores natural gas-to-liquids chemistry, CO2 reduction to methanol, and hydrogen production through catalytic processes. His work often combines photochemical and thermal approaches to achieve multi-electron reductions necessary for energy storage.
Analysis of his recent publications reveals a strong trend toward applied research with industrial partnerships, particularly in catalytic processes for energy conversion. While maintaining his expertise in ruthenium chemistry for medical applications, his recent work shows increased focus on practical catalytic systems for natural gas conversion and CO2 utilization. The research demonstrates sophisticated integration of molecular design with practical engineering considerations for scale-up.
- Academy of Distinguished Scholars, University of Texas at Arlington (2021)
- Distinguished Record of Research, UTA (2014)
- Outstanding Teacher Award, UTA College of Science (2012)
- Outstanding Research Achievement, UTA College of Science (2003)
- Damon Runyon Cancer Research Fellowship (1992)
Dr. MacDonnell has successfully mentored numerous graduate students including Amir Jafari, Cynthia Griffith, Oluchukwu Igboenyesi, Matthew Guerrero, and Melissa Reardon. His research program has been supported by substantial funding from federal agencies including NSF, NIH, and DOE, as well as industry partners like Greenway Innovative Energy and TRT Holdings. His laboratory facilities support advanced synthesis, photochemical studies, and catalytic testing, with notable equipment including NMR spectrometers upgraded through NSF funding. Current research directions include developing more efficient catalysts for natural gas conversion and optimizing ruthenium complexes for targeted cancer therapy with reduced side effects.
